Metabolism of the Hepatotoxic Compound Sophoraflavanone G in Rat Liver Microsomes

Journal of Food Science

Volumn 79, Issue 7, 2014, Pages

  Chen, Ping ^a   Zhang, Xiuwen ^a   Huang, Taomin ^a   Yu, Qianqian ^a   Cheng, Nengneng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Hepatotoxicity; Metabolism; RLMs; Sophoraflavanone G

Indexed keywords

RATTUS; SOPHORA FLAVESCENS;

CYTOCHROME P450; FLAVANONE DERIVATIVE; VEXIBINOL;

ANIMAL; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; KINETICS; LIVER MICROSOME; MALE; METABOLISM; PLANT ROOT; RAT; SOPHORA;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; FLAVANONES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; KINETICS; MALE; MICROSOMES, LIVER; PLANT ROOTS; RATS; SOPHORA;

EID: 84904313159     PISSN: 00221147     EISSN: 17503841     Source Type: Journal    
DOI: 10.1111/1750-3841.12501     Document Type: Article

References (35)

1. Bogaards JJ, Bertrand M, Jackson P, Oudshoorn MJ, Weaver RJ, van Bladeren PJ, Walther B. 2000. Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 30(12):1131-52.
2. Cha JD, Jeong MR, Jeong SI, Lee KY. 2007. Antibacterial activity of sophoraflavanone G isolated from the roots of Sophora flavescens. J Microbiol Biotechnol 17(5):858-64.
3. Cha JD, Moon SE, Kim JY, Jung EK, Lee YS. 2009. Antibacterial activity of sophoraflavanone G isolated from the roots of Sophora flavescens against methicillin-resistant Staphylococcus aureus. Phytother Res 23(9):1326-31.
4. Chi YS, Jong HG, Son KH, Chang HW, Kang SS, Kim HP. 2001. Effects of naturally occurring prenylated flavonoids on enzymes metabolizing arachidonic acid: cyclooxygenases and lipoxygenases. Biochem Pharmacol 62(9):1185-91.
5. Choi YH, Lee MG. 2006. Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin. British Journal of J Pharmacologypharmacol 149(4):424-30.
6. Chung HJ, Choi YH, Kim SH, Lee MG. 2006. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in rats. J Pharm Pharmacol 58(4):449-57.
7. Di Marco A, D'Antoni M, Attaccalite S, Carotenuto P, Laufer R. 2005. Determination of drug glucuronidation and UDP-glucuronosyltransferase selectivity using a 96-well radiometric assay. Drug Metab Dispos 33(6):812-9.
8. Du F, Liu Z, Li X, Xing J. 2013. Metabolic pathways leading to detoxification of triptolide, a major active component of the herbal medicine Tripterygium wilfordii. J Appl Toxicology: Jat. DOI: 10.1002/jat.2906.
9. Eagling VA, Tjia JF, Back DJ. 1998. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Br J Clin Pharmacol 45(2):107-14.
10. Gnojkowski J, Baer-Dubowska W, Klimek D, Chmiel J. 1984. Effect of toluidines on drug metabolizing enzymes in rat liver, kidney and lung. Toxicology 32(4):335-42.
11. Houston JB, Kenworthy KE. 2000. In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model. Drug Metab Dispos 28(3):246-54.
12. Hwang JS, Lee SA, Hong SS, Lee KS, Lee MK, Hwang BY, Ro JS. 2005. Monoamine oxidase inhibitory components from the roots of Sophora flavescens. Arch Pharm Res 28(2):190-4.
13. Jin JH, Kim JS, Kang SS, Son KH, Chang HW, Kim HP. 2010. Anti-inflammatory and anti-arthritic activity of total flavonoids of the roots of Sophora flavescens. J Ethnopharmacol 127(3):589-95.
14. Jing WH, Song YL, Yan R, Wang YT. 2013. Identification of cytochrome P450 isoenzymes involved in metabolism of (+)-praeruptorin A, a calcium channel blocker, by human liver microsomes using ultra high-performance liquid chromatography coupled with tandem mass spectrometry. J Pharmaceut Biomed Anal 77:175-88.
15. Kamdem LK, Liu Y, Stearns V, Kadlubar SA, Ramirez J, Jeter S, Shahverdi K, Ward BA, Ogburn E, Ratain MJ, Flockhart DA, Desta Z. 2010. In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole. Br J Clin Pharmacol 70(6):854-69.
16. Kang TH, Jeong SJ, Ko WG, Kim NY, Lee BH, Inagaki M, Miyamoto T, Higuchi R, Kim YC. 2000. Cytotoxic lavandulyl flavanones from Sophora flavescens. J Nat Prod 63(5):680-1.
17. Ko WG, Kang TH, Kim NY, Lee SJ, Kim YC, Ko GI, Ryu SY, Lee BH. 2000. Lavandulylflavonoids: a new class of in vitro apoptogenic agents from Sophora flavescens. Toxicol In Vitro 14(5):429-33.
18. Kobayashi K, Urashima K, Shimada N, Chiba K. 2003. Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat. Drug Metab Dispos 31(7):833-6.
19. Lee HS, Ji HY, Park EJ, Kim SY. 2007. In vitro metabolism of eupatilin by multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes. Xenobiotica 37(8):803-17.
20. Li AF, Shen GL, Jiao SY, Li H, Wang Q. 2012. Metabolic detoxification of bakuchiol is mediated by cytochrome P450 enzymes in human liver microsomes. Beijing Da Xue Xue Bao 44(3):431-6.
21. Liu YT, Hao K, Liu XQ, Wang GJ. 2006. Metabolism and metabolic inhibition of gambogic acid in rat liver microsomes. Acta Pharmacol Sin 27(9):1253-8.
22. Liu Y, Hao H, Xie H, Lv H, Liu C, Wang G. 2009. Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats. J Pharmaceut Sci 98(11):4391-01.
23. Mandlekar SV, Rose AV, Cornelius G, Sleczka B, Caporuscio C, Wang J, Marathe PH. 2007. Development of an in vivo rat screen model to predict pharmacokinetic interactions of CYP3A4 substrates. Xenobiotica 37(9):923-42.
24. Mano Y, Usui T, Kamimura H. 2007. Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes. Drug Metab Dispos 35(4):602-6.
25. Radominska-Pandya A, Bratton S, Little JM. 2005. A historical overview of the heterologous expression of mammalian UDP-glucuronosyltransferase isoforms over the past twenty years. Curr Drug Metab 6(2):141-60.
26. Ruan H, Zhang Z, Liang XF, Fu Y, Su MQ, Liu QL, Wang XM, Zhu X. 2011. Metabolism of dl-praeruptorin A in rat liver microsomes using HPLC-electrospray ionization tandem mass spectrometry. Arch Pharmacal Res 34(8):1311-21.
27. Shi R, Zhou H, Ma B, Ma Y, Wu D, Wang X, Luo H, Cheng N. 2012. Pharmacokinetics and metabolism of jatrorrhizine, a gastric prokinetic drug candidate. Biopharm Drug Dispos 33(3):135-45.
28. Song WY, Ji HY, Baek NI, Jeong TS, Lee HS. 2010. In vitro metabolism of jaceosidin and characterization of cytochrome P450 and UDP-glucuronosyltransferase enzymes in human liver microsomes. Arch Pharm Res 33(12):1985-96.
29. Tian H, Ou J, Strom SC, Venkataramanan R. 2005. Activity and expression of various isoforms of uridine diphosphate glucuronosyltransferase are differentially regulated during hepatic regeneration in rats. Pharm Res 22(12):2007-15.
30. Tucker GT, Houston JB, Huang SM. 2001. Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential-toward a consensus. Pharma Res 18(8):1071-80.
31. Uchaipichat V, Winner LK, Mackenzie PI, Elliot DJ, Williams JA, Miners JO. 2006. Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation. Br J Clin Pharmacol 61(4):427-39
32. Yan Z, Caldwell GW. 2013. In vitro identification of cytochrome P450 enzymes responsible for drug metabolism. Methods Mol Biol 1015:251-61.
33. Yu Q, Cheng N, Ni X. 2013. Identifying 2 prenylflavanones as potential hepatotoxic compounds in the ethanol extract of Sophora flavescens. J Food Sci 78(11):T1830-4.
34. Zhang L, Xu L, Xiao SS, Liao QF, Li Q, Liang J, Chen XH, Bi KS. 2007. Characterization of flavonoids in the extract of Sophora flavescens Ait. by high-performance liquid chromatography coupled with diode-array detector and electrospray ionization mass spectrometry. J Pharma Biomed Anal 44(5):1019-28.
35. Zhou SF, Xue CC, Yu XQ, Wang G. 2007. Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update. Curr Drug Metab 8(6):526-53.